百药智达(北京)纳米生物技术有限公司王力源获国家专利权
买专利卖专利找龙图腾,真高效! 查专利查商标用IPTOP,全免费!专利年费监控用IP管家,真方便!
龙图腾网获悉百药智达(北京)纳米生物技术有限公司申请的专利核酸载体、核酸药及其制备方法和应用获国家发明授权专利权,本发明授权专利权由国家知识产权局授予,授权公告号为:CN117343965B 。
龙图腾网通过国家知识产权局官网在2025-06-13发布的发明授权授权公告中获悉:该发明授权的专利申请号/专利号为:202310871667.8,技术领域涉及:C12N15/87;该发明授权核酸载体、核酸药及其制备方法和应用是由王力源;魏鸿;王萌设计研发完成,并于2023-07-14向国家知识产权局提交的专利申请。
本核酸载体、核酸药及其制备方法和应用在说明书摘要公布了:本发明提供了一种核酸载体、核酸药及其制备方法和应用。核酸载体包含a、b和c序列,核酸载体选自DNA、RNA或DNA‑RNA混合载体;a、b和c序列自组装形成核酸载体,a、b和c序列包括包括如下核心序列的骨架序列:SEQIDNO:1或4所示的a1序列、SEQIDNO:2或5所示的b1序列和SEQIDNO:3或6所示的c1序列,或者a1序列、b1序列和c1序列中至少之一的任意变异序列,变异序列包括至少一个碱基的插入、缺失或替换;DNA‑RNA混合载体为DNA载体的序列和RNA载体的序列的组合所自组装形成的载体。该载体递送效率高,递送系统更稳定。且在制备工艺上也更简单高效。
本发明授权核酸载体、核酸药及其制备方法和应用在权利要求书中公布了:1.一种核酸载体,其特征在于,所述核酸载体包含a序列、b序列和c序列,所述a序列、所述b序列和所述c序列作为所述核酸载体的骨架序列,自组装形成所述核酸载体的所述骨架序列分别选择如下任意一组: 1a序列:SEQIDNO:21:GCGACGCCCACGAGCGTTCCGGGAGAGGAG, b序列:SEQIDNO:22:CTCCTCTCCCGGTTCGCCGCGAGCCGCG, c序列:SEQIDNO:23:CGCGGCACGCGGCCATAGCCGTGGGCGTCGC; 2a序列:SEQIDNO:24:GCGACGCCCACGAGCGTTCCGGGAGAGGAGCT,b序列:SEQIDNO:19:GCTCCTCTCCCGGTTCGCCGCGAGCCGCG, c序列:SEQIDNO:23:CGCGGCACGCGGCCATAGCCGTGGGCGTCGC; 3a序列:SEQIDNO:24:GCGACGCCCACGAGCGTTCCGGGAGAGGAGCT,b序列:SEQIDNO:25:GCTCCTCTCCCGGTTCGCCGCGAGCCGCGT, c序列:SEQIDNO:26:CGCGGCTCGCGGCCATAGCCGTGGGCGTCGCT; 4a序列:SEQIDNO:24:GCGACGCCCACGAGCGTTCCGGGAGAGGAGCT,b序列:SEQIDNO:25:GCTCCTCTCCCGGTTCGCCGCGAGCCGCGT, c序列:SEQIDNO:27:CGCGGCACGCGGCCATAGCCGTGGGCGTCGCT; 5a序列:SEQIDNO:28:GACGCCCACGAGCGTTCCGGGAGAGG, b序列:SEQIDNO:29:CCTCTCCCGGTTCGCCGCGAGCC, c序列:SEQIDNO:30:GGCTCGCGGCCATAGCCGTGGGCGTC; 6a序列:SEQIDNO:18:GCGACGCCCACGAGCGTTCCGGGAGAGGAGC,b序列:SEQIDNO:19:GCTCCTCTCCCGGTTCGCCGCGAGCCGCG, c序列:SEQIDNO:31:CGCGGCTCGCGGCCATAGCCGTGGGCGTCGC; 7a序列:SEQIDNO:24:GCGACGCCCACGAGCGTTCCGGGAGAGGAGCT,b序列:SEQIDNO:19:GCTCCTCTCCCGGTTCGCCGCGAGCCGCG, c序列:SEQIDNO:26:CGCGGCTCGCGGCCATAGCCGTGGGCGTCGCT; 8a序列:SEQIDNO:24:GCGACGCCCACGAGCGTTCCGGGAGAGGAGCT,b序列:SEQIDNO:19:GCTCCTCTCCCGGTTCGCCGCGAGCCGCG,c序列:SEQIDNO:31:CGCGGCTCGCGGCCATAGCCGTGGGCGTCGC; 9a序列:SEQIDNO:24:GCGACGCCCACGAGCGTTCCGGGAGAGGAGCT,b序列:SEQIDNO:25:GCTCCTCTCCCGGTTCGCCGCGAGCCGCGT,c序列:SEQIDNO:26:CGCGGCTCGCGGCCATAGCCGTGGGCGTCGCT; 10a序列:SEQIDNO:24:GCGACGCCCACGAGCGTTCCGGGAGAGGAGCT,b序列:SEQIDNO:25:GCTCCTCTCCCGGTTCGCCGCGAGCCGCGT,c序列:SEQIDNO:31:CGCGGCTCGCGGCCATAGCCGTGGGCGTCGC; 11a序列:SEQIDNO:18:GCGACGCCCACGAGCGTTCCGGGAGAGGAGC;b序列:SEQIDNO:25:GCTCCTCTCCCGGTTCGCCGCGAGCCGCGT; c序列:SEQIDNO:26:CGCGGCTCGCGGCCATAGCCGTGGGCGTCGCT; 12a序列:SEQIDNO:32:CGACGCCCACGAGCGTTCCGGGAGAGGAGC;b序列:SEQIDNO:19:GCTCCTCTCCCGGTTCGCCGCGAGCCGCG; c序列:SEQIDNO:31:CGCGGCTCGCGGCCATAGCCGTGGGCGTCGC; 13a序列:SEQIDNO:33:GCGGCGCCCACGAGCGTTCCGGGAGC; b序列:SEQIDNO:34:GCTCCCGGTTCGCCGCCAGCCGCC; c序列:SEQIDNO:35:GGCGGCAGGCGGCCATAGCCGTGGGCGCCGC; 14a序列:SEQIDNO:36:GCGGCGCCCACGAGCGTTCCGGGAGAGGCC;b序列:SEQIDNO:37:GGCCTCTCCCGGTTCGCCGCCAGCCGCC; c序列:SEQIDNO:38:GGCGGCTGGCGGCCATAGCCGTGGGCGCCGC; 15a序列:SEQIDNO:39:GCGGCGCCCACGAGCGTTCCGGGAGAGGCCT;b序列:SEQIDNO:40:GGCCTCTCCCGGTTCGCCGCCAGCCGCCT; c序列:SEQIDNO:41:GGCGGCTGGCGGCCATAGCCGTGGGCGCCGCT; 16a序列:SEQIDNO:42:GCGGCGCCCACGAGCGUUCCGGGAGAGGCC;b序列:SEQIDNO:43:GGCCUCUCCCGGUUCGCCGCCAGCCGCC; c序列:SEQIDNO:44:GGCGGCUGGCGGCCAUAGCCGUGGGCGCCGC; 17a序列:SEQIDNO:45:CGACGCCCACGAGCGTTCCGGGAGAGGAG;b序列:SEQIDNO:46:CTCCTCTCCCGGTTCGCCGCCAGCCGCC; c序列:SEQIDNO:35:GGCGGCAGGCGGCCATAGCCGTGGGCGCCGC; 18a序列:SEQIDNO:36:GCGGCGCCCACGAGCGTTCCGGGAGAGGCC;b序列:SEQIDNO:43:GGCCUCUCCCGGUUCGCCGCCAGCCGCC; c序列:SEQIDNO:44:GGCGGCUGGCGGCCAUAGCCGUGGGCGCCGC; 19a序列:SEQIDNO:36:GCGGCGCCCACGAGCGTTCCGGGAGAGGCC;b序列:SEQIDNO:40:GGCCTCTCCCGGTTCGCCGCCAGCCGCCT; c序列:SEQIDNO:38:GGCGGCTGGCGGCCATAGCCGTGGGCGCCGC; 20a序列:SEQIDNO:36:GCGGCGCCCACGAGCGTTCCGGGAGAGGCC;b序列:SEQIDNO:40:GGCCTCTCCCGGTTCGCCGCCAGCCGCCT; c序列:SEQIDNO:41:GGCGGCTGGCGGCCATAGCCGTGGGCGCCGCT; 21a序列:SEQIDNO:36:GCGGCGCCCACGAGCGTTCCGGGAGAGGCC;b序列:SEQIDNO:37:GGCCTCTCCCGGTTCGCCGCCAGCCGCC; c序列:SEQIDNO:44:GGCGGCUGGCGGCCAUAGCCGUGGGCGCCGC; 22a序列:SEQIDNO:33:GCGGCGCCCACGAGCGTTCCGGGAGC; b序列:SEQIDNO:46:CTCCTCTCCCGGTTCGCCGCCAGCCGCC; c序列:SEQIDNO:35:GGCGGCAGGCGGCCATAGCCGTGGGCGCCGC; 23a序列:SEQIDNO:47:GCGGCGCCCACGAGCGTTCCGGGAGAGGAG;b序列:SEQIDNO:46:CTCCTCTCCCGGTTCGCCGCCAGCCGCC; c序列:SEQIDNO:35:GGCGGCAGGCGGCCATAGCCGTGGGCGCCGC; 24a序列:SEQIDNO:48:CGCCCACGAGCGTTCCGGGAGA; b序列:SEQIDNO:49:TCTCCCGGTTCGCCGCGAG; c序列:SEQIDNO:50:CTCGCGGCCATAGCCGTGGGCG; 25a序列:SEQIDNO:51:UCGCCCACGAGCGUUCCGGGAGA; b序列:SEQIDNO:52:UCUCCCGGUUCGCCGCGAG; c序列:SEQIDNO:53:UCUCGCGGCCAUAGCCGUGGGCG; 26a序列:SEQIDNO:54:GCGCCCACGAGCGTTCCGGGAGAGC; b序列:SEQIDNO:55:CCCUGCTCTCCCGGTTCGCCGCCAGCCGCC; c序列:SEQIDNO:56:GGCGGCAGGCGGCCATAGCCGTGGGCGC。
如需购买、转让、实施、许可或投资类似专利技术,可联系本专利的申请人或专利权人百药智达(北京)纳米生物技术有限公司,其通讯地址为:102206 北京市海淀区海淀南路21号8层8-1-1;或者联系龙图腾网官方客服,联系龙图腾网可拨打电话0551-65771310或微信搜索“龙图腾网”。
1、本报告根据公开、合法渠道获得相关数据和信息,力求客观、公正,但并不保证数据的最终完整性和准确性。
2、报告中的分析和结论仅反映本公司于发布本报告当日的职业理解,仅供参考使用,不能作为本公司承担任何法律责任的依据或者凭证。